Evidence map›Paper›PMID 35050690›Full record

ReviewCirculation research2022

Platelet and Megakaryocyte Roles in Innate and Adaptive Immunity.

Milka Koupenova, Alison C Livada, Craig N Morrell

Open access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 1 pooled it
24.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 1 synthesis or guideline pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Inflammation, anemia, and vitamin D levels associate with infant thrombocytosis risk.Research and practice in thrombosis and haemostasis · 2026
    Article
  18. Engineering platelets as cancer therapeutics.Nature reviews. Clinical oncology · 2026
    Review
  19. Article
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Milka KoupenovaDepartment of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Chan Medical School, Worcester (M.K.).ORCID 0000-0001-5934-8990
Alison C LivadaAab Cardiovascular Research Institute (A.C.L., C.N.M.), University of Rochester Medical Center, NY.ORCID 0000-0002-2886-8819
Craig N MorrellAab Cardiovascular Research Institute (A.C.L., C.N.M.), University of Rochester Medical Center, NY.ORCID 0000-0001-9131-4862
University of Rochester Medical Center · USUniversity of Massachusetts Chan Medical School · US

Funding

University of Massachusetts Center for Clinical Science and Translational SupplementUL1TR001453 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2015 to 2024
$39.0M
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injuryR01HL142152 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MORRELL, CRAIG N, SILVERSTEIN, ROY L · 2019 to 2022
$2.5M
Novel mechanisms of platelet modified monocyte phenotypeR01HL141106 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N · 2018 to 2021
$2.2M
Mechanisms of platelet reprogramming during influenza infectionR01HL153235 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KOUPENOVA, MILKA · 2020 to 2024
$2.1M
Platelet-Regulated Immune Responses in Neonates Following TransfusionR21HL153409 · NHLBI · UNIVERSITY OF ROCHESTER · PI MORRELL, CRAIG N, PALIS, JAMES · 2020 to 2021
$424k
The Origin and Function of Lung MegakaryocytesF30HL165822 · NHLBI · UNIVERSITY OF ROCHESTER · PI LIVADA, ALISON CLAIRE · 2023 to 2025
$161k
NCATS NIH HHS UL1 TR001453NHLBI NIH HHS F30 HL165822NHLBI NIH HHS R01 HL141106NHLBI NIH HHS R01 HL142152NHLBI NIH HHS R01 HL153235NHLBI NIH HHS R21 HL153409
6 · The paper itself

Abstract

Classically, platelets have been described as the cellular blood component that mediates hemostasis and thrombosis. This important platelet function has received significant research attention for >150 years. The immune cell functions of platelets are much less appreciated. Platelets interact with and activate cells of all branches of immunity in response to pathogen exposures and infection, as well as in response to sterile tissue injury. In this review, we focus on innate immune mechanisms of platelet activation, platelet interactions with innate immune cells, as well as the intersection of platelets and adaptive immunity. The immune potential of platelets is dependent in part on their megakaryocyte precursor providing them with the molecular composition to be first responders and immune sentinels in initiating and orchestrating coordinated pathogen immune responses. There is emerging evidence that extramedullary megakaryocytes may be immune differentiated compared with bone marrow megakaryocytes, but the physiological relevance of immunophenotypic differences are just beginning to be explored. These concepts are also discussed in this review. The immune functions of the megakaryocyte/platelet lineage have likely evolved to coordinate the need to repair a vascular breach with the simultaneous need to induce an immune response that may limit pathogen invasion once the blood is exposed to an external environment.

Indexed as

Adaptive ImmunityImmunity, InnateAnimalsBlood PlateletsHumansMegakaryocytesblood plateletscomplement system proteinsextracellular trapsimmunitymegakaryocytethrombosistoll-like receptors

Identifiers

PMID35050690
PMCPMC8852355
OpenAlexW4206012410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.